Batavia Biosciences has announced its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been eradicated.   In support of the polio eradication initiative, novel oral polio vaccine (nOPV) candidates are being developed that are intended to reduce...